Sonic Healthcare Ltd (SHL.AX) stock: key figures, P/E, revenue and dividend

Health Care · Australia · ISIN AU000000SHL7

Price

19.07 AUD

Market cap

9.43 bn AUD

P/E (2026)

15.51

P/S (2026)

0.86

Dividend yield

8.63 %

Net margin

5.55 %

Return on equity (ROE)

7.29 %

Return on assets (ROA)

3.62 %

Sonic Healthcare Ltd financials

Fiscal year	2025	2026
Revenue	9.65 bn AUD	10.95 bn AUD
Gross profit	3.19 bn AUD	3.03 bn AUD
EBIT	936.00 m AUD	1.09 bn AUD
Net income	513.00 m AUD	608.00 m AUD
Diluted EPS – continuing operations	1.04 AUD	1.23 AUD

Full history since 1989, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Sonic Healthcare Ltd

Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It also offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, general practice IT solutions, and community-based healthcare services, as well as clinical trials services. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.